Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SYNTHROID | AbbVie | N-021402 RX | 2002-07-24 | 12 products, RLD |
THYRO-TABS | Alvogen | N-021116 RX | 2002-10-24 | 12 products, RLD |
THYQUIDITY | Azurity | N-214047 RX | 2020-11-30 | 1 products, RLD, RS |
LEVO-T | Cediprof | N-021342 RX | 2002-03-01 | 12 products |
LEVOTHYROXINE SODIUM | Fresenius Kabi | N-202231 RX | 2011-06-24 | 3 products, RLD, RS |
LEVOTHYROXINE SODIUM | Fresenius Kabi | N-210632 RX | 2019-04-11 | 3 products, RLD, RS |
LEVOLET | Genus Lifesciences | N-021137 RX | 2003-06-06 | 12 products |
LEVOTHYROXINE SODIUM | Hikma Pharmaceuticals | N-214253 RX | 2021-05-17 | 1 products, RLD, RS |
TIROSINT | IBSA Group | N-021924 RX | 2006-10-13 | 15 products, RLD |
TIROSINT-SOL | IBSA Group | N-206977 RX | 2016-12-15 | 15 products, RLD, RS |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Levothyroxine Sodium, Tirosint-Sol, Ibsa | |||
11241382 | 2039-09-17 | U-3757, U-3758 | |
10537538 | 2037-02-28 | DP | |
11096913 | 2037-02-28 | DP | |
Levothyroxine Sodium, Levolet, Genus Lifesciences | |||
10231931 | 2038-03-23 | DP | |
10406108 | 2038-03-23 | DP | |
Levothyroxine Sodium, Levothyroxine Sodium, Fresenius Kabi Usa | |||
9782376 | 2036-12-01 | DP | |
10398669 | 2036-12-01 | DP | |
11135190 | 2036-12-01 | DP | |
9006289 | 2032-10-03 | DP | |
9168238 | 2032-08-29 | DP | |
9168239 | 2032-08-29 | DP | |
Levothyroxine Sodium, Levothyroxine Sodium, Hikma | |||
11154498 | 2036-07-20 | DP | |
Levothyroxine Sodium, Ermeza, Mylan | |||
9345772 | 2035-02-27 | DP | |
Levothyroxine Sodium, Thyquidity, Azurity | |||
9050307 | 2031-08-06 | DP | |
Levothyroxine Sodium, Tirosint, Ibsa | |||
7691411 | 2024-03-14 | DP | |
7723390 | 2024-03-14 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypothyroidism | D007037 | EFO_0004705 | E03.9 | 1 | 10 | 3 | 22 | 38 | 72 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | 2 | 4 | 3 | 1 | 9 | 18 |
Healthy volunteers/patients | — | — | — | 11 | 1 | — | 2 | 1 | 14 |
Heart failure | D006333 | HP_0001635 | I50 | — | 1 | 1 | 3 | 5 | 10 |
Thyroid diseases | D013959 | HP_0000820 | E00-E07 | — | 2 | 1 | 2 | 5 | 10 |
Congenital hypothyroidism | D003409 | — | E00.1 | — | — | — | 2 | 5 | 7 |
Graves disease | D006111 | EFO_0004237 | E05.0 | — | 1 | 2 | 3 | 1 | 6 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | 2 | 2 | 4 |
Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | 1 | — | 2 | — | 3 |
Down syndrome | D004314 | EFO_0001064 | Q90 | — | — | 1 | 1 | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | 1 | — | 4 | 5 |
Neoplasms | D009369 | — | C80 | 1 | 1 | 1 | — | 2 | 4 |
Dyslipidemias | D050171 | HP_0003119 | — | — | — | 2 | — | 2 | 4 |
Brain death | D001926 | — | G93.82 | 1 | 1 | 1 | — | 1 | 3 |
Thyrotoxicosis | D013971 | — | E05 | — | 1 | 1 | — | 1 | 3 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | 1 | — | 2 | 3 |
Hyperthyroxinemia | D006981 | EFO_0004127 | — | — | — | 2 | — | 1 | 3 |
Tetanus | D013742 | EFO_0005593 | A35 | — | 1 | 2 | — | — | 3 |
Diphtheria | D004165 | EFO_0005549 | A36 | — | 1 | 2 | — | — | 3 |
Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autoimmune thyroiditis | D013967 | EFO_0006812 | E06.3 | — | 1 | — | — | 5 | 6 |
Leukemia | D007938 | — | C95 | 5 | 6 | — | — | — | 6 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 3 | — | — | 2 | 5 |
Lymphoma | D008223 | — | C85.9 | 4 | 5 | — | — | — | 5 |
Infertility | D007246 | HP_0000789 | — | — | 1 | — | — | 1 | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 1 | — | — | — | 2 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 1 | — | — | 1 | 2 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 2 | — | — | — | 2 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 2 | — | — | — | 2 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | — | 6 | 7 |
Hyperthyroidism | D006980 | — | E05.9 | 1 | — | — | — | 4 | 5 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | — | — | — | — | 2 |
Residual neoplasm | D018365 | — | — | 2 | — | — | — | — | 2 |
Philadelphia chromosome | D010677 | — | — | 2 | — | — | — | — | 2 |
Melanosis | D008548 | HP_0001480 | L81.1 | 1 | — | — | — | 1 | 2 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Glioblastoma | D005909 | EFO_0000515 | — | 1 | — | — | — | — | 1 |
Follicular lymphoma | D008224 | — | C82 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hashimoto disease | D050031 | EFO_0003779 | E06.3 | — | — | — | — | 5 | 5 |
Pregnancy rate | D018873 | — | — | — | — | — | — | 3 | 3 |
Coronary disease | D003327 | — | — | — | — | — | — | 3 | 3 |
Epilepsy | D004827 | EFO_0000474 | G40.9 | — | — | — | — | 3 | 3 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 2 | 2 |
Temporomandibular joint disorders | D013705 | — | M26.6 | — | — | — | — | 2 | 2 |
Thoracic aortic aneurysm | D017545 | EFO_0004282 | — | — | — | — | — | 2 | 2 |
Aortic aneurysm | D001014 | EFO_0001666 | I71.9 | — | — | — | — | 2 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 2 | 2 |
Keratoconus | D007640 | EFO_0004223 | H18.6 | — | — | — | — | 2 | 2 |
Drug common name | Levothyroxine |
INN | levothyroxine sodium |
Description | L-thyroxine is the L-enantiomer of thyroxine. It has a role as a thyroid hormone, an antithyroid drug, a human metabolite and a mouse metabolite. It is a thyroxine, an iodophenol, a 2-halophenol, a L-phenylalanine derivative and a non-proteinogenic L-alpha-amino acid. It is a conjugate acid of a L-thyroxine(1-). It is an enantiomer of a D-thyroxine. It is a tautomer of a L-thyroxine zwitterion. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O |
PDB | — |
CAS-ID | 51-48-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1624 |
ChEBI ID | 18332 |
PubChem CID | 5819 |
DrugBank | DB00451 |
UNII ID | 054I36CPMN (ChemIDplus, GSRS) |